药捷安康-B早盘涨近11%创上市新高 公司获纳入港股通名单

新浪港股
Sep 08
热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易
客户端

  药捷安康-B(02617)早盘涨超10%,盘中高见78港元,刷新上市新高。截至发稿,涨10.54%,报69.75港元,成交额5433.80万港元。

  上交所、深交所发布公告,药捷安康被调入港股通标的名单,自9月8日起生效。此外,药捷安康近日宣布,公司核心产品替恩戈替尼(Tinengotinib, TT-00420)分别联用康方生物科技(开曼)有限公司开坦尼®(卡度尼利,PD-1/CTLA-4)╱依达方®(依沃西,PD-1/VEGF)的治疗晚期肝细胞癌(hepatocellular carcinoma, HCC)的开放性、多中心II期临床研究,于近日完成首例患者给药。

海量资讯、精准解读,尽在新浪财经APP

责任编辑:卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10